Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital
Abstract Clinical pharmacists have been increasing their participation mainly through actions aimed at patient care, with international studies demonstrating favorable cost-benefit ratio from pharmacists interventions. However, there are few studies carried out in Brazil about the subject. This stud...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade de São Paulo
2023-01-01
|
| Series: | Brazilian Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100834&tlng=en |
| _version_ | 1797957090911715328 |
|---|---|
| author | Leandro Gouveia Carneiro Karine Dal Paz Eliane Ribeiro |
| author_facet | Leandro Gouveia Carneiro Karine Dal Paz Eliane Ribeiro |
| author_sort | Leandro Gouveia Carneiro |
| collection | DOAJ |
| description | Abstract Clinical pharmacists have been increasing their participation mainly through actions aimed at patient care, with international studies demonstrating favorable cost-benefit ratio from pharmacists interventions. However, there are few studies carried out in Brazil about the subject. This study aims to assess the economic impact of pharmaceutical interventions (PIs) in a hospital setting performed in October 2018. Each performed PI was registered and associated with the direct cost of drugs for economic impact analysis. A total of 185 PIs were evaluated, comprising 106 patients. The most intervened drugs were antibiotics, presenting the greatest economic impact, R$2,370. The total economic impact was R$2,578, mainly in the Pediatric Intensive Care Unit that represented R$1,701. Regarding the economic impact by PI as the “Suspension of drug without indication” saved R$1,360 while the “Inclusion of required drugs” cost R$807. It was estimated that the savings would be R$30,936 and, if PIs were performed at day zero, the savings would be R$79,728 per year. An average of 1.75 PI per patient was performed with an economic impact of R$14 per PI. Our results showed that clinical pharmacist’s role in the evaluation of pharmacotherapy is important for patients’ health and represents a positive economic impact. |
| first_indexed | 2024-04-10T23:58:56Z |
| format | Article |
| id | doaj.art-659d42f436c444ffb1ecb53aebc93c38 |
| institution | Directory Open Access Journal |
| issn | 2175-9790 |
| language | English |
| last_indexed | 2024-04-10T23:58:56Z |
| publishDate | 2023-01-01 |
| publisher | Universidade de São Paulo |
| record_format | Article |
| series | Brazilian Journal of Pharmaceutical Sciences |
| spelling | doaj.art-659d42f436c444ffb1ecb53aebc93c382023-01-10T07:31:54ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902023-01-015810.1590/s2175-97902022e201198Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospitalLeandro Gouveia Carneirohttps://orcid.org/0000-0002-7758-1822Karine Dal PazEliane RibeiroAbstract Clinical pharmacists have been increasing their participation mainly through actions aimed at patient care, with international studies demonstrating favorable cost-benefit ratio from pharmacists interventions. However, there are few studies carried out in Brazil about the subject. This study aims to assess the economic impact of pharmaceutical interventions (PIs) in a hospital setting performed in October 2018. Each performed PI was registered and associated with the direct cost of drugs for economic impact analysis. A total of 185 PIs were evaluated, comprising 106 patients. The most intervened drugs were antibiotics, presenting the greatest economic impact, R$2,370. The total economic impact was R$2,578, mainly in the Pediatric Intensive Care Unit that represented R$1,701. Regarding the economic impact by PI as the “Suspension of drug without indication” saved R$1,360 while the “Inclusion of required drugs” cost R$807. It was estimated that the savings would be R$30,936 and, if PIs were performed at day zero, the savings would be R$79,728 per year. An average of 1.75 PI per patient was performed with an economic impact of R$14 per PI. Our results showed that clinical pharmacist’s role in the evaluation of pharmacotherapy is important for patients’ health and represents a positive economic impact.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100834&tlng=enPharmaceutical interventionDirect costsEconomic impactHospital setting |
| spellingShingle | Leandro Gouveia Carneiro Karine Dal Paz Eliane Ribeiro Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital Brazilian Journal of Pharmaceutical Sciences Pharmaceutical intervention Direct costs Economic impact Hospital setting |
| title | Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital |
| title_full | Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital |
| title_fullStr | Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital |
| title_full_unstemmed | Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital |
| title_short | Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital |
| title_sort | economic impact of pharmaceutical interventions in a medium complexity brazilian university hospital |
| topic | Pharmaceutical intervention Direct costs Economic impact Hospital setting |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100834&tlng=en |
| work_keys_str_mv | AT leandrogouveiacarneiro economicimpactofpharmaceuticalinterventionsinamediumcomplexitybrazilianuniversityhospital AT karinedalpaz economicimpactofpharmaceuticalinterventionsinamediumcomplexitybrazilianuniversityhospital AT elianeribeiro economicimpactofpharmaceuticalinterventionsinamediumcomplexitybrazilianuniversityhospital |